$CERT News
Last published 6d ago
- 6d agoCERTCertara, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 6d agoCERTCertara Reports Third Quarter 2026 Financial ResultsGlobeNewswireCertara delivers a solid quarter with double-digit software revenue growth Updates 2026 financial outlook Appoints Grant Peterson Chief Product Officer Company to host conference call and webcast today at 8:30 a.m.
- 2w agoCERTCertara to Report Third Quarter 2026 Financial Results on November 5th, 2026GlobeNewswireRADNOR, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that it will release financial results for the third quarter of 2026
- 2mo agoHYFTVEEVILMNCERT+1The Market Just Told You Which Layer Of AI Biology It Is Paying ForGlobeNewswireAUSTIN, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Market Updates News Commentary - Earnings season in life sciences technology has just delivered an unusually clean verdict. The company that owns the industry’s data
- 3mo agoCERTCertara Second Quarter 2026 Earnings Conference Call - CERTARA INCEarnings Call TranscriptsGood day, and thank you for standing by. Welcome to the Sartara Second Quarter 2026 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a qu
- 3mo agoCERTCertara Reports Second Quarter 2026 Financial ResultsGlobeNewswireAppoints Julien Perrier Chief Commercial Officer Completes previously authorized $100 million share repurchase program; Board authorizes additional $50 million under repurchase program Reaffirms 2026 revenue guidance
- 3mo agoHYFTSDGRABCLRLAY+1An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the NumbersPR NewswireFor years, the promise of artificial intelligence in drug discovery has been easy to describe and hard to monetize. Plenty of companies can talk...
- 3mo agoCERTCertara to Report Second Quarter 2026 Financial Results on August 4th, 2026GlobeNewswireRADNOR, Pa., July 15, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that it will release financial results for the second quarter of 2026
- 4mo agoCERTCertara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent ToolkitGlobeNewswireRADNOR, Pa., July 07, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, is partnering with NVIDIA to advance Certara's open integrated AI platform, unifying
- 4mo agoHYFTABSICERTAZN+1As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the ModelsPR NewswireUSA News Group News Commentary — A growing consensus in artificial intelligence holds that the models themselves are becoming interchangeable, and...
- 4mo agoCERTCertara Announces CFO TransitionGlobeNewswireRADNOR, Pa., June 17, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, announces that John Gallagher, Chief Financial Officer, has notified the Company of his
- 4mo agoHYFTABSIRXRXSDGR+1The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath ItPR NewswireEquity Insider News Commentary — The story the market has been telling itself about artificial intelligence and drug discovery is, at its core, a...
- 5mo agoCERTJEFFERIES GLOBAL HEALTHCARE CONFERENCE IN NEW YORK - CERTARA INCEarnings Call TranscriptsAll right, folks. Thanks for joining us. Dave Windley with Jeffries Healthcare Equity Research. We're here at Jeffries' 2026 Global Healthcare Conference. And on the Wednesday afternoon, glad to be joined by Sartara and
- 5mo agoCERTCertara to Participate in Upcoming Investor ConferencesGlobeNewswireRADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor
- 6mo agoCERTCertara First Quarter 2026 Earnings Conference Call - CERTARA INCEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Sitara first quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a quest
- 6mo agoCERTCertara Third Quarter 2026 Earnings Conference Call - CERTARA INCEarnings Call TranscriptsThis video tutorial shows how to install Kali Linux 2017.1 LXDE on VMware Workstation or VMware Workspace. Kali LXD is a very simple and easy-to-use software that can be installed on your computer. To install it, click o
- 6mo agoCERTCertara Reports First Quarter 2026 Financial ResultsGlobeNewswireRADNOR, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today reported its first quarter 2026 financial results. First Quarter Highlights:
- 6mo agoCERTAltasciences and Certara Announce Strategic Partnership to Accelerate Early Drug DevelopmentBusiness WireAltasciences, a fully integrated drug development solution company, and Certara (NASDAQ:CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase
- 6mo agoCERTCertara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to VeristatGlobeNewswireTransaction sharpens focus on Model-Informed Drug Development (MIDD) and Clinical Intelligence Updated 2026 guidance to be provided upon transaction close RADNOR, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- Certara,
- 7mo agoCERTCertara to Report First Quarter 2026 Financial Results on May 11th, 2026GlobeNewswireRADNOR, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that it will release financial results for the first quarter of 2026
- 8mo agoCERTCertara at the Barclays 28th Annual Global Healthcare Conference - CERTARA INCEarnings Call TranscriptsGood afternoon, everybody. I'm Luke Serga. I cover life science tools and diagnostics. With me today, I have John Gallagher, CFO of Sertara. Thanks again for making it. Hi, Luke. Thanks for having me. Under the bright li
- 8mo agoCERTLeerink Global Healthcare Conference - CERTARA INCEarnings Call Transcriptsgreat uh good morning everyone uh welcome to the first session of layering global healthcare conference i'm mike cherny the healthcare tech and distribution analyst it's my pleasure to have with us sartara uh john gallag
- 8mo agoCERTCertara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminibGlobeNewswireRADNOR, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced its Simcyp® Simulator enabled physiologically-based pharmacokinetic
- 8mo agoCERTCertara to Participate in Upcoming Investor ConferencesGlobeNewswireRADNOR, Pa., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor
- 8mo agoCERTCertara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 GuidanceGlobeNewswireFY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth Quarter Revenue of $103.6M (3% growth) and Adj. EBITDA of $32.5M (-3% decline) FY 2026 Revenue Growth of 0-4% FY 2026 Adjusted
- 9mo agoCERTCertara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025GlobeNewswireRADNOR, Pa., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full
- 11mo agoAMZNABSICERTSOPHAI Creation Engines Transform Biotech as Wellness Tech Captures Growth WavePR NewswireEquity Insider News Commentary – Major pharmaceutical companies are cutting drug discovery timelines by 30% or more through AI models that predict...
- 11mo agoCERTCTSHDOCSOSCRHealthcare AI Exits Pilot Phase, Enters Production DeploymentGlobeNewswireVANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – Healthcare organizations are setting the pace for enterprise AI adoption as operational automation moves from
- 11mo agoCERTCertara Appoints Jon Resnick as Chief Executive OfficerGlobeNewswireResnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth William Feehery to step down as CEO on December 31, 2025 Company reaffirms full year
- 1y agoCERTCertara Reports Third Quarter 2025 Financial ResultsGlobeNewswireRADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025. Third
- 1y agoCERTCertara Third Quarter 2025 Earnings Conference Call - CERTARA INCEarnings Call TranscriptsGood day and thank you for standing by. Welcome to the Sitara third quarter 2025 earnings conference call. At this time, our participants are in listen only mode. After the speaker's presentation, there will be a questio
- 1y agoCERTCertara Automates Scientific Workflows with Phoenix® CloudGlobeNewswireRADNOR, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced the launch of TFL Studio, the first cloud-native module of its Phoenix
- 1y agoCERTCertara to Participate in Upcoming Investor ConferencesGlobeNewswireRADNOR, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor
- 1y agoCERTCertara Expands Biosimulation Market with AI-Driven QSP PlatformGlobeNewswireRADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems
- 1y agoCERTCertara Scientists are Among the Topmost Cited Biopharma ResearchersGlobeNewswireRADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced its continued influence in pharmaceutical research. With more than 200
- 1y agoCERTCertara to Report Third Quarter 2025 Financial Results on November 6th, 2025GlobeNewswireRADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close
- 1y agoCERTCertara, Inc. (CERT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
- 1y agoCERTCertara, Inc. (CERT) Presents At Baird Global Healthcare Conference 2025 (Transcript)Earnings Call Transcripts
- 1y agoCERTCertara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions FasterGlobeNewswireRADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in biosimulation, today announced the availability of Pinnacle 21 Enterprise Plus. The solution enables clinical and
- 1y agoCERTCertara to Participate in Upcoming Investor ConferencesGlobeNewswireRADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor
- 1y agoCERTCertara, Inc. (CERT) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoCERTCertara Reports Second Quarter 2025 Financial ResultsGlobeNewswireRADNOR, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today reported its financial results for the second quarter of fiscal year 2025. Second
- 1y agoCERTCertara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK ModelingGlobeNewswireRADNOR, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc., a global leader in biosimulation, today announced that the European Medicines Agency (EMA) has formally qualified the Simcyp® Simulator for use in
- 1y agoCERTCertara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development PlatformGlobeNewswireRADNOR, Pa., July 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced the appointment of Christopher Bouton, Ph.D., as Chief Technology Officer.
- 1y agoCERTCertara Announces Expansion of Clinical Technology Collaboration with MerckGlobeNewswireRADNOR, Pa., July 08, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced a new collaboration with Merck, known as MSD outside of the United States
- 1y agoRENBCERTCCLDMSFTAI Could Add $461 Billion to Global Healthcare--And These New Platforms Are Leading the ChargePR NewswireEquity Insider News Commentary – A new report from Philips reveals a growing divide between doctors and patients when it comes to AI in healthcare....
- 1y agoCERTCertara Reports First Quarter 2025 Financial ResultsGlobeNewswireRADNOR, Pa., May 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today reported its financial results for the first quarter of fiscal year 2025. First
- 1y agoCERTCertara to Participate in Upcoming Investor ConferencesGlobeNewswireRADNOR, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor
- 1y agoCERTCertara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal TestingGlobeNewswireRADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, today announced the launch of its Non-Animal Navigator™ solution designed to help
- 1y agoCERTCertara Reports Preliminary First Quarter 2025 Financial Results; Announces $100 Million Share Repurchase AuthorizationGlobeNewswireReiterates Full-Year 2025 GuidanceArsenal Capital Partners agrees to a one-year lock-up RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug